Use of microcalorimetry in determination of stability of enalapril maleate and enalapril maleate tablet formulations

被引:20
|
作者
Simoncic, Z.
Zupancic, P.
Roskar, R.
Gartner, A.
Kogej, K.
Kmetec, V.
机构
[1] Krka DD Novo Mesto, Novo Mesto 8501, Slovenia
[2] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia
[3] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia
关键词
isothermal microcalorimetry; chromatography; enalapril maleate; stability; active substance; formulation;
D O I
10.1016/j.ijpharm.2007.05.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The stability properties of enalapril maleate (EM) and of different tablet formulations including EM were studied by isothermal microcalorimetry and by high performance liquid chromatography (HPLC). It was shown that water content of the sample and elevated temperature have a high impact on stability properties of the substance itself and of the formulations including this substance. The degradation is more extensive at higher water content and at elevated temperature. The type of the tablet formulation (5 or 20 mg EM tablet formulation) also has an impact: the 5 EM tablet formulation is the less stable one. The heat output of individual tablet formulations was used to evaluate the enthalpy changes and to calculate the difference in the amount of degraded EM between various samples. These results agreed satisfactorily with those obtained by HPLC. Isothermal microcalorimetry proved to be a fast and predictive method that could be used in preformulation studies to accelerate the pharmaceutical development and shorten the time before launching the product to the market. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 50 条
  • [1] Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations
    Al-Omari, MM
    Abdelah, MK
    Badwan, AA
    Jaber, AMY
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 25 (5-6) : 893 - 902
  • [2] Determination of hydrochlorothiazide and enalapril maleate in tablet formulations by reversed-phase HPLC
    Al-Momani, IF
    TURKISH JOURNAL OF CHEMISTRY, 2001, 25 (01): : 49 - 54
  • [3] Proposal of a new degradation mechanism of enalapril maleate and improvement of enalapril maleate stability in tablet formulation with different stabilizers
    Chen, J.
    Zhang, L. H.
    Xu, R. J.
    Bu, N. J.
    Zhang, L.
    PHARMAZIE, 2014, 69 (04): : 277 - 280
  • [4] Pharmacokinetic parameters and relative bioavailability of two tablet formulations of enalapril maleate
    Abou-Basha, LI
    Wahman, LF
    Gharib, HA
    Tantway, WH
    INSTRUMENTATION SCIENCE & TECHNOLOGY, 2005, 33 (01) : 1 - 8
  • [5] Enalapril maleate
    Davidson, G
    Horeish, C
    COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN, 1999, 21 (12): : 1118 - +
  • [6] CRITERIA FOR USE OF ENALAPRIL MALEATE IN ADULTS
    COLEY, AL
    CLINICAL PHARMACY, 1991, 10 (01): : 63 - 67
  • [7] DESIGN AND EVALUATION OF A NEW FORMULATION OF ENALAPRIL MALEATE TABLET
    Bibi, Rehana
    Naqvi, Baqir Shyum
    Shoaib, Muhammad Harris
    Rahim, Najia
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 24 (02) : 211 - 215
  • [8] USE OF ENALAPRIL MALEATE IN DIABETIC NEPHROPATHY
    ARGUEDAS, C
    FUCHS, J
    HYPERTENSION, 1989, 13 (05) : 507 - 507
  • [9] Enalapril maleate form II: stabilization in a tablet formulation
    Eyjolfsson, R
    PHARMAZIE, 2003, 58 (05): : 357 - 357
  • [10] BIOAVAILABILITY OF ENALAPRIL MALEATE
    IRVIN, JD
    TILL, AE
    VLASSES, PH
    HICHENS, M
    ROTMENSCH, HH
    HARRIS, KE
    MERRILL, DD
    FERGUSON, RK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (02) : 248 - 248